BIOMAT Database Logo BIOMAT Database Logo

Opsoclonus-Myoclonus-Ataxia Syndrome Due to Covid-19. 2024

Michael Adamaszek, and Soenke Langner, and Jan Mehrholz, and Alexander Heiinrich
Department of Neurological and Neurocognitive Rehabilitation, Klinik Bavaria Kreischa, An der Wolfsschlucht, 1-2 01731, Kreischa, Germany. michael.adamaszek@klinik-bavaria.de.

Opsoclonus-myoclonus syndrome (OMS) as a rare neurological encephalopathic entity associated with non-specific infections or cancer processes has been repeatedly described in the setting of SARS-CoV-2 infection. We report a case of a 53-year-old man with SARS-CoV-2 infection, who developed clinical features of opsoclonus-myoclonus ataxia syndrome including cognitive impairments with a prolonged course of disease. Of particular note, cerebrospinal fluid (CSF) analysis revealed the production of myelin oligodendrocyte glycoprotein (MOG) antibodies, suggesting an underlying neuroimmunological mechanism associated with infection with the novel SARS-CoV-2 virus.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D053578 Opsoclonus-Myoclonus Syndrome A neurological condition that is characterized by uncontrolled rapid irregular movements of the eye (OPSOCLONUS) and the muscle (MYOCLONUS) causing unsteady, trembling gait. It is also known as dancing eyes-dancing feet syndrome and is often associated with neoplasms, viral infections, or autoimmune disorders involving the nervous system. Paraneoplastic Opsoclonus-Myoclonus Ataxia,Dancing Eyes, Dancing Feet Syndrome,Dancing Eyes-Dancing Feet Syndrome,Kinsbourne Syndrome,Myoclonic Encephalopathy of Infants,Opsoclonus Myoclonus,Opsoclonus Myoclonus Ataxia,Dancing Eyes Dancing Feet Syndrome,Infants Myoclonic Encephalopathies,Infants Myoclonic Encephalopathy,Myoclonus, Opsoclonus,Opsoclonus Myoclonus Syndrome,Paraneoplastic Opsoclonus Myoclonus Ataxia
D063308 Myelin-Oligodendrocyte Glycoprotein A transmembrane protein present in the MYELIN SHEATH of the CENTRAL NERVOUS SYSTEM. It is one of the main autoantigens implicated in the pathogenesis of MULTIPLE SCLEROSIS. MOG Glycoprotein,Glycoprotein, Myelin-Oligodendrocyte,Myelin Oligodendrocyte Glycoprotein

Related Publications

Michael Adamaszek, and Soenke Langner, and Jan Mehrholz, and Alexander Heiinrich
Opsoclonus myoclonus ataxia syndrome following COVID-19 infection.
April 2023, Acta neurologica Belgica,
Michael Adamaszek, and Soenke Langner, and Jan Mehrholz, and Alexander Heiinrich
Opsoclonus-Myoclonus-Ataxia Syndrome Related to the Novel Coronavirus (COVID-19).
September 2021, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society,
Michael Adamaszek, and Soenke Langner, and Jan Mehrholz, and Alexander Heiinrich
Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2.
January 2023, Neuro-ophthalmology (Aeolus Press),
Michael Adamaszek, and Soenke Langner, and Jan Mehrholz, and Alexander Heiinrich
[Ataxia-opsoclonus-myoclonus syndrome].
January 1981, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
Michael Adamaszek, and Soenke Langner, and Jan Mehrholz, and Alexander Heiinrich
Opsoclonus myoclonus ataxia syndrome.
January 2018, Neurology India,
Michael Adamaszek, and Soenke Langner, and Jan Mehrholz, and Alexander Heiinrich
Opsoclonus Myoclonus Ataxia Syndrome in the Setting of COVID-19 Infection.
January 2021, Neurology,
Michael Adamaszek, and Soenke Langner, and Jan Mehrholz, and Alexander Heiinrich
A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome.
February 2024, Journal of infection in developing countries,
Michael Adamaszek, and Soenke Langner, and Jan Mehrholz, and Alexander Heiinrich
78-year-old woman with opsoclonus myoclonus ataxia syndrome secondary to COVID-19.
May 2021, BMJ case reports,
Michael Adamaszek, and Soenke Langner, and Jan Mehrholz, and Alexander Heiinrich
Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome.
April 2023, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus,
Michael Adamaszek, and Soenke Langner, and Jan Mehrholz, and Alexander Heiinrich
[Paraneoplastic opsoclonus myoclonus ataxia syndrome].
January 2009, Anales del sistema sanitario de Navarra,
Copied contents to your clipboard!